SCHEMBL27074906

SCHEMBL27074906

Cc1n[nH]c2cnc(N(C)C3CCOCC3)cc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 2/20 0.38
▸ PDE6D O43924 1/20 0.38
▸ PDE6A P16499 1/20 0.38
▸ PDE6G P18545 1/20 0.38
▸ PDE6B P35913 1/20 0.38
▸ PDE6C P51160 1/20 0.38
▸ PDE6H Q13956 1/20 0.38
▸ LMNA P02545 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ ADORA2A P29274 1/20 0.33
▸ ADORA2B P29275 1/20 0.33
▸ PDE4B Q07343 1/20 0.33
▸ ELOVL1 Q9BW60 1/20 0.33
▸ IRAK4 Q9NWZ3 1/20 0.33
▸ IDH1 O75874 1/20 0.33
▸ JAK3 P52333 1/20 0.32
▸ S1PR1 P21453 1/20 0.32
▸ S1PR3 Q99500 1/20 0.32
▸ LRRK2 Q5S007 4/20 0.32
▸ PIM1 P11309 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27074905 0.85 JAK2 (0.33) ADORA2AADORA2BLRRK2JAK2
SCHEMBL27074823 0.79 FGFR1 (0.39) PDE10APDE6DPDE6APDE6GPDE6B
SCHEMBL30729184 0.78 PDE6D (0.37) PDE10APDE6DPDE6APDE6GPDE6B
SCHEMBL27075031 0.78 PDE6D (0.37) PDE10APDE6DPDE6APDE6GPDE6B
SCHEMBL27074745 0.78 PDE10A (0.37) PDE10APDE6DPDE6APDE6GPDE6B
SCHEMBL30729195 0.76 PDE6D (0.40) PDE10APDE6DPDE6APDE6GPDE6B
SCHEMBL27075014 0.76 PDE6D (0.40) PDE10APDE6DPDE6APDE6GPDE6B
SCHEMBL30729153 0.73 IRAK4 (0.35) PDE10APDE6DPDE6APDE6GPDE6B
SCHEMBL27074710 0.73 IRAK4 (0.35) PDE10APDE6DPDE6APDE6GPDE6B
SCHEMBL27074723 0.71 PDE6D (0.38) PDE10APDE6DPDE6APDE6GPDE6B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240034736-A1 HSD17B13 INHIBITORS AND USES THEREOF FL2022-001, INC. 2024-02-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240034736-A1 HSD17B13 INHIBITORS AND USES THEREOF HSD17B3, HSD17B11, HSD17B1 PDE10A 1138/4885PDE6D 2802/4885PDE6A 2663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback